Edema is a medical condition characterized by the accumulation of excess fluid in the body’s tissues, leading to swelling and ...

The next generation of professional athletes relies on the sam® wearable ultrasound unit from ZetrOZ Systems to recover ...

Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of ...

Introduction: The Convergence of AI and Life SciencesTraditionally, drug discovery is a time-consuming and costly process, ...

The Interventional Oncology Market is poised for significant growth, projected to reach USD 3.9 billion by 2025, expanding at ...

VANCOUVER, BC / ACCESS Newswire / April 30, 2025 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality ...

Hiring the right Laravel development company is not just about technical skills. It's about finding a team that understands ...

AstraZeneca is discontinuing the CAPItello-280 Phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis with a level ...

NCIMB Limited ("NCIMB"), a leading microbiology services provider and owner of the UK’s largest industrial, food and marine bacterial culture collection, has secured a £1.7m investment from the ...

Emsculpt NEO's role in aesthetic and functional wellness will be the focus of the upcoming BODYWELLE-hosted event in Miami Beach, featuring demos and expert insights. MIAMI BEACH, FLORIDA / ACCESS ...

TORONTO, ON / ACCESS Newswire / April 30, 2025 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") announces the resignation of Mr. Richard Yoon from its Board of Directors, ...